SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Psychedelics and the Human Receptorome
2 references·16 citing·44 second hop
Psychedelics and the Human Receptorome (2010)Psychedelics and the Human ReceptoromeDifferences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens (1986)Differences Between the Mecha…Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents (1984)Evidence for 5-HT2 involvemen…Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice (2021)Prolonged epigenomic and syna…Survey of entity encounter experiences occasioned by inhaled N,N -dimethyltryptamine: Phenomenology, interpretation, and enduring effects (2020)Survey of entity encounter ex…Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms (2020)Psychedelics in Psychiatry: N…Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species (2020)Correlation between the poten…A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms (2019)A single inhalation of vapor …Unifying Theories of Psychedelic Drug Effects (2018)Unifying Theories of Psychede…N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function (2018)N, N-Dimethyltryptamine (DMT)…Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults (2017)Pharmacokinetics of Escalatin…Chemistry and Structure–Activity Relationships of Psychedelics (2017)Chemistry and Structure–Activ…Serotonergic Hallucinogen-Induced Visual Perceptual Alterations (2016)Serotonergic Hallucinogen-Ind…Clinical applications of hallucinogens: A review. (2016)Clinical applications of hall…Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities (2015)Psychedelics and Immunomodula…Classic hallucinogens in the treatment of addictions (2015)Classic hallucinogens in the …Psilocybin – Summary of knowledge and new perspectives (2013)Psilocybin – Summary of knowl…Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses (2012)Therapeutic mechanisms of cla…Head‐twitch response in rodents induced by the hallucinogen 2,5‐dimethoxy‐4‐iodoamphetamine: a comprehensive history, a re‐evaluation of mechanisms, and its utility as a model (2012)Head‐twitch response in roden…Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)Hallucinogens (2004)Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects (2011)Characterization of the head-twitch response induced by hallucinogens in mice (2013)The promises and perils of psychedelic pharmacology for psychiatry (2022)Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Human hallucinogen research: guidelines for safety (2008)Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD (2017)Developing Guidelines and Competencies for the Training of Psychedelic Therapists (2017)DMT Models the Near-Death Experience (2018)Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA (2016)Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development (2018)The Therapeutic Potential of Psilocybin (2021)Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study (2016)Psychedelics (2016)Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions (2018)Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences (2020)Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review (2022)The Satisfaction With Life Scale (1985)The short‐form version of the Depression Anxiety Stress Scales (DASS‐21): Construct validity and normative data in a large non‐clinical sample (2005)Using Self-Report Assessment Methods to Explore Facets of Mindfulness (2006)Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment (2019)A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats (2021)Spontaneous and deliberate creative cognition during and after psilocybin exposure (2021)Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)Psychedelic-Inspired Drug Discovery Using an Engineered Biosensor (2020)Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential (2023)The size and burden of mental disorders and other disorders of the brain in Europe 2010 (2011)Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 (2013)Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015)Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity (2022)A non-hallucinogenic LSD analog with therapeutic potential for mood disorders (2023)Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review (2023)The Epidemiology of Major Depressive Disorder (2003)Psychedelics and Other Psychoplastogens for Treating Mental Illness (2021)Shared and Distinct Brain Regions Targeted for Immediate Early Gene Expression by Ketamine and Psilocybin (2023)Broadband Cortical Desynchronization Underlies the Human Psychedelic State (2013)Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution (2016)Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function (2018)Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug (1992)Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers (1998)Gender differences in the subjective effects of MDMA (2001)
this work references cited by second hop

References

  • 1984Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents631 cited
  • 1986Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens563 cited

Cited by

  • 2020Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species276 cited
  • 2013Psilocybin – Summary of knowledge and new perspectives275 cited
  • 2020Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms231 cited
  • 2015Classic hallucinogens in the treatment of addictions226 cited
  • 2021Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice223 cited
  • 2012Head‐twitch response in rodents induced by the hallucinogen 2,5‐dimethoxy‐4‐iodoamphetamine: a comprehensive history, a re‐evaluation of mechanisms, and its utility as a model221 cited
  • 2016Clinical applications of hallucinogens: A review.201 cited
  • 2019A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms197 cited
  • 2017Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults188 cited
  • 2018Unifying Theories of Psychedelic Drug Effects182 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2018N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function177 cited
  • 2015Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities150 cited
  • 2020Survey of entity encounter experiences occasioned by inhaled N,N -dimethyltryptamine: Phenomenology, interpretation, and enduring effects146 cited
  • 2012Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses125 cited
  • 2017Chemistry and Structure–Activity Relationships of Psychedelics114 cited
  • 2016Serotonergic Hallucinogen-Induced Visual Perceptual Alterations112 cited